Semaglutide (Standard Pen) research pen
BESTSELLER
In stockResearch use only

Aesthetics & Regenerative • Metabolic & Fat Optimization

Semaglutide (Standard Pen)

Semaglutide — the GLP-1 receptor agonist that redefined weight-loss research.

$153.12$191.40Save 20%
Size

2 pens for complete course · 1 pen lasts ~140 days

1
Suggested research dosage
Dose: 0,25mg/week, may be increased to 0,5mg or 1mg/week. Units: 10units/week may be increased to 20 or 40units/week
Course
Once per week. From 6 months to as long as needed.
  • ✓ ≥99% purity (HPLC)
  • ✓ Batch-matched COA
  • ✓ Cold-chain 2–8°C
  • ✓ Tracked delivery
  • ✓ Tamper-evident
  • ✓ EU + US shipping
Overview

What is Semaglutide (Standard Pen)?

Semaglutide is a long-acting GLP-1 receptor agonist with 94% homology to native GLP-1, engineered for weekly subcutaneous dosing. STEP trial program demonstrated ~15% mean body-weight reduction.

Each PeptidePen is filled in a controlled cleanroom and sealed with tamper-evident packaging. Batch documentation includes identity confirmation, HPLC purity analysis and concentration verification. Strictly for in-vitro research — not for human or veterinary use.

Research library

Go deeper on Semaglutide (Standard Pen)

A full breakdown of mechanism, clinical findings, dosing references and safety signals — for researchers who want the complete picture.

What is Semaglutide?

Semaglutide is a medication used to treat type 2 diabetes. It belongs to the incretin class, involved in insulin production by the pancreas, helps reduce blood glucose levels, and speeds up metabolism.

Continue reading the full research brief

Semaglutide is a new-generation product that effectively controls blood sugar and helps normalize healthy weight. This peptide shows potential not only for diabetes management but also for improving overall body condition. Semaglutide can be combined with other diabetes treatments to support their effects and enhance the overall quality of life.

The peptide Semaglutide has demonstrated positive effects on body weight regulation by suppressing appetite and promoting a feeling of satiety. It also contributes to improving blood pressure and cholesterol levels, which may reduce the risk of cardiovascular problems.

What are the benefits of Semaglutide?

Semaglutide is an analogue of incretin hormones that regulate glucose levels in the body. It is used in type 2 diabetes and to improve general body condition. The known benefits of Semaglutide include:

● Increasing insulin production and helping control blood sugar levels. — ● Improving liver function, which reduces the risk of fat accumulation in the liver. — ● Playing an important role in controlling sugar levels, thereby reducing the risk of diabetic complications, kidney damage, and eye redness. — ● Reducing appetite and sending satiety signals to the body, promoting healthy weight loss. — ● Enhancing overall health and protecting against diseases related to diabetes. — ● Helping diabetics maintain better blood glucose control by lowering the risk of hypoglycemia. — ● Stimulating the feeling of satiety, helping diabetics normalize healthy weight. — ● Lowering blood glucose levels by stimulating insulin release from the pancreas.

While Semaglutide is not a cure for type 2 diabetes, it can be used as part of a comprehensive treatment plan to improve general body condition.

Semaglutide Clinical Trials and Results

Semaglutide has successfully passed all clinical trials, demonstrating high effectiveness and safety for participants with type 2 diabetes.

One major clinical trial, SUSTAIN 6, involved 3,000 diabetic participants. Results showed a significant reduction in the risk of heart attacks and strokes with Semaglutide use.

Other clinical trials confirmed the peptide's positive impact on reducing blood glucose levels, stimulating insulin secretion, improving glycemic control, and supporting healthy weight management.

In summary, clinical studies show that Semaglutide has a highly positive effect in treating type 2 diabetes.

Proper Intake and Dosage of Semaglutide

Please note that the Semaglutide 5 mg pens have updated dosage settings. Refer to the new instructions below:

Dosage: — The correct Semaglutide dosage depends on individual conditions. It is advisable to consult a qualified specialist to determine the appropriate dose and administration method.

Suggested Research Protocol: — Semaglutide is administered once a week. The usual starting dose is 0.25 mg, which can be increased to 0.5 mg or 1 mg as needed. If a dose is missed, take it as soon as possible but never double the dose.

Additional Instructions: — ● 1 unit equals 1 programmer division (or the number displayed when the dispenser is turned). — ● Apply to the abdominal area or the front of the thigh. — ● After application, wait 10 seconds before removing the pen. — ● Rotate application sites regularly.

Pen Information: — ● One Semaglutide 5 mg pen contains 200 units of 25 mcg each.

Example conversions for the 5 mg pen: — ○ 1 unit = 25 mcg — ○ 10 units = 0.25 mg — ○ 20 units = 0.50 mg — ○ 30 units = 0.75 mg — ○ 40 units = 1 mg

● One Semaglutide 1 mg pen contains 100 units of 10 mcg each.

Example conversions for the 1 mg pen: — ○ 1 unit = 10 mcg — ○ 10 units = 0.10 mg — ○ 20 units = 0.20 mg — ○ 25 units = 0.25 mg — ○ 50 units = 0.5 mg

Possible Side Effects of Semaglutide

Semaglutide is used to treat type 2 diabetes, and like any medication, side effects may occur, often due to improper use.

Possible side effects include headache, nausea, diarrhea, constipation, and mild itching around the application site.

These side effects are generally mild and usually disappear within a few days. It is essential to consult a specialist and follow their instructions and prescribed dosages to minimize side effects.

Research highlights

Why researchers choose Semaglutide (Standard Pen)

  • 01

    ~15% mean body-weight reduction in trials

  • 02

    Strong appetite and craving suppression

  • 03

    Improves HbA1c and cardiovascular endpoints

  • 04

    Weekly dosing — convenient titration

Research protocol

Typical dosing reference

Standard titration: 0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg weekly SC.

For in-vitro research design reference only.

Specifications

Specifications

Form

Pre-mixed pen

Purity

≥99% HPLC

Storage

2–8°C

Shipping

Cold-chain

COA

Batch-matched

Stacks well with

Researchers often pair this with

Tirzepatide (transition)BPC-157 (GI)L-Carnitine
Reported in research

Known side-effect signals

  • Nausea
  • Constipation
  • Sulfur burps
  • Gallbladder events at high dose
From order to lab bench

Built for trust at every step

  1. 01

    Place your order

    Select pen size and shipping region at checkout.

  2. 02

    Verify the COA

    Each batch is HPLC-assayed and documented.

  3. 03

    Cold-chain ships

    Insulated, temperature-logged delivery.

  4. 04

    Run your protocol

    Reference dosing and references included.

FAQ

Frequently asked questions

Common questions about Semaglutide (Standard Pen) and PeptidePen orders.

Is Semaglutide (Standard Pen) for human use?+

No. All PeptidePen products are strictly for in-vitro laboratory research. Not intended for human or veterinary use.

How is the COA provided?+

Each pen ships with a batch-matched certificate of analysis. A digital copy is also available on request via your order confirmation.

How is shipping handled?+

Orders ship cold-chain (2–8°C) with insulated packaging, ice packs and a temperature log. Tracked delivery in the US and EU.

Can I order in bulk for my lab?+

Yes. Contact our team for institutional pricing, custom concentrations and recurring shipments.

What's your refund policy?+

Damaged or off-spec pens are replaced free of charge. Contact support within 7 days of delivery.

Ready to run Semaglutide (Standard Pen) in your next study?

Pre-mixed, batch-assayed, cold-chain shipped — order before 2pm for same-day dispatch.

Related
View all →